(Q35580451)

9 August 2017

1 reference

title

Advances in the understanding and treatment of nonalcoholic fatty liver disease (English)

1 reference

9 August 2017

Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease (English)

1 reference

https://api.crossref.org/works/10.2165/00003495-200363220-00001

metabolic dysfunction–associated steatotic liver disease

30 March 2024

main subject

1 reference

inferred from title

author

Adrian M. Di Bisceglie

series ordinal

2

object named as

Adrian M Di Bisceglie

1 reference

9 August 2017

Stephen A. Harrison

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609346

30 March 2024

language of work or name

1 reference

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

63

1 reference

9 August 2017

issue

22

1 reference

9 August 2017

page(s)

2379-2394

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363220-00001

9 August 2017

exact match

0 references

cites work

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

12 December 2020

Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease

1 reference

12 December 2020

Nonalcoholic fatty liver disease: an agenda for clinical research

1 reference

12 December 2020

Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells

1 reference

12 December 2020

Fat and the liver--a molecular overview

1 reference

12 December 2020

Orlistat in the treatment of NASH: a case series

1 reference

12 December 2020

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

12 December 2020

Prevalence of fatty liver in a general population of Okinawa, Japan

1 reference

12 December 2020

Metformin reverses fatty liver disease in obese, leptin-deficient mice

1 reference

12 December 2020

Syndrome X: 10 years after

1 reference

12 December 2020

Function and activation of NF-kappa B in the immune system

1 reference

12 December 2020

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

1 reference

12 December 2020

Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells

1 reference

12 December 2020

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

12 December 2020

The natural history of nonalcoholic fatty liver: a follow-up study

1 reference

12 December 2020

Liver fibrosis in overweight patients

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Fatty liver hepatitis and cirrhosis in obese patients

1 reference

12 December 2020

Diabetes mellitus, obesity, and hepatic steatosis.

1 reference

12 December 2020

Metformin in non-alcoholic steatohepatitis.

1 reference

12 December 2020

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

12 December 2020

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

1 reference

12 December 2020

Hepatic iron and nonalcoholic fatty liver disease.

1 reference

12 December 2020

Apolipoprotein synthesis in nonalcoholic steatohepatitis

1 reference

12 December 2020

Leptin selectively decreases visceral adiposity and enhances insulin action.

1 reference

12 December 2020

Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?

1 reference

12 December 2020

Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study

1 reference

12 December 2020

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

1 reference

12 December 2020

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

1 reference

12 December 2020

Post-jejunoileal-bypass Hepatic Disease: Its Similarity to Alcoholic Hepatic Disease

1 reference

12 December 2020

Diabetes, obesity, and Acrp30/adiponectin

1 reference

12 December 2020

Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes

1 reference

12 December 2020

Is NASH underdiagnosed among African Americans?

1 reference

12 December 2020

1 reference

12 December 2020

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

12 December 2020

Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice

1 reference

12 December 2020

PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes

1 reference

12 December 2020

Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity

1 reference

12 December 2020

Mitochondria in steatohepatitis

1 reference

12 December 2020

The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

1 reference

12 December 2020

Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

1 reference

12 December 2020

Nonalcoholic Steatohepatitis

1 reference

12 December 2020

Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease.

1 reference

12 December 2020

A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Injury produced by free fatty acids to lysosomes and mitochondria in cultured heart muscle and endothelial cells.

1 reference

12 December 2020

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

1 reference

12 December 2020

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

12 December 2020

Liver impairment in the obese

1 reference

12 December 2020

Treatment of nonalcoholic fatty liver: present and emerging therapies

1 reference

12 December 2020

Hepatic steatosis, insulin resistance, and adipose tissue disorders.

1 reference

12 December 2020

1 reference

12 December 2020

Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects

1 reference

12 December 2020

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

12 December 2020

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

12 December 2020

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Insulin resistance-associated hepatic iron overload.

1 reference

12 December 2020

Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system

1 reference

12 December 2020

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

1 reference

12 December 2020

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

12 December 2020

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

12 December 2020

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

12 December 2020

Non-alcoholic steatohepatitis in children and adolescents

1 reference

12 December 2020

Insulin signalling and the regulation of glucose and lipid metabolism

1 reference

12 December 2020

Cytokines and fibrogenesis

1 reference

12 December 2020

Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury.

1 reference

12 December 2020

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

1 reference

12 December 2020

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

1 reference

12 December 2020

Obesity as a medical problem

1 reference

12 December 2020

Nonalcoholic steatohepatitis: a study of 49 patients

1 reference

12 December 2020

Liver pathology and the metabolic syndrome X in severe obesity.

1 reference

12 December 2020

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

1 reference

12 December 2020

Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines

1 reference

12 December 2020

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

1 reference

12 December 2020

Oxidative stress-related molecules and liver fibrosis

1 reference

12 December 2020

Hepatic effects of dietary weight loss in morbidly obese subjects

1 reference

12 December 2020

Leptin regulates proinflammatory immune responses

1 reference

12 December 2020

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

12 December 2020

Treatment of obesity: need to focus on high risk abdominally obese patients

1 reference

12 December 2020

Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones

1 reference

12 December 2020

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

12 December 2020

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

1 reference

12 December 2020

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Diabetes: the importance of the liver

1 reference

12 December 2020

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

12 December 2020

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

1 reference

12 December 2020

Mitochondrial abnormalities in non-alcoholic steatohepatitis

1 reference

12 December 2020

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

1 reference

12 December 2020

Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population

1 reference

12 December 2020

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

1 reference

12 December 2020

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

1 reference

12 December 2020

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

1 reference

12 December 2020

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

12 December 2020

Steatohepatitis: a tale of two "hits"?

1 reference

12 December 2020

Mitochondrial adaptations to obesity-related oxidant stress

1 reference

12 December 2020

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

1 reference

12 December 2020

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

1 reference

12 December 2020

Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM

1 reference

12 December 2020

Orlistat, a new lipase inhibitor for the management of obesity

1 reference

12 December 2020

Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease

1 reference

12 December 2020

Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

1 reference

12 December 2020

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance

1 reference

12 December 2020

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

12 December 2020

Leptin, obesity, and liver disease

1 reference

12 December 2020

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

12 December 2020

Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion

1 reference

12 December 2020

Serum leptin levels in patients with nonalcoholic steatohepatitis.

1 reference

12 December 2020

Effect of weight reduction on hepatic abnormalities in overweight patients

1 reference

12 December 2020

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

12 December 2020

Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes

1 reference

12 December 2020

Lipoatrophy revisited

1 reference

12 December 2020

Liver morphology and function tests in obesity and during total starvation

1 reference

12 December 2020

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

12 December 2020

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

1 reference

12 December 2020

Insulin action and insulin resistance in human skeletal muscle

1 reference

12 December 2020

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

12 December 2020

Peroxisomal beta-oxidation and steatohepatitis

1 reference

12 December 2020

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

1 reference

12 December 2020

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

1 reference

12 December 2020

Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey

1 reference

12 December 2020

Analysis of paradoxical observations on the association between leptin and insulin resistance

1 reference

12 December 2020

3

55

434

Ludwig

1980

1 reference

https://api.crossref.org/works/10.2165/00003495-200363220-00001

Seminars in gastrointestinal disease

30 March 2024

37

13

17

Youssef

2002

1 reference

https://api.crossref.org/works/10.2165/00003495-200363220-00001

30 March 2024

Journal of Immunology

94

159

97

Matsui

1997

1 reference

https://api.crossref.org/works/10.2165/00003495-200363220-00001

Book Review Ethical Problems in Dialysis and Transplantation (Developments in Nephrology. Vol. 33.) Edited by Carl M. Kjellstrand and John B. Dossetor. 235 pp., illustrated. Boston, Kluwer Academic, 1992. $108.50. 0-7923-1625-8

30 March 2024

series ordinal

95

1 reference

https://api.crossref.org/works/10.2165/00003495-200363220-00001

The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy

30 March 2024

series ordinal

119

1 reference

https://api.crossref.org/works/10.2165/00003495-200363220-00001

30 March 2024

Identifiers

1 reference

Dimensions Publication ID

9 August 2017

1000961287

0 references

1 reference